Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
SOP Plug-and-play starting point Clinical & GCP

SOP: CRO and Service Provider Qualification and Selection

A plug-and-play SOP for risk-based qualification and selection of clinical CROs and service providers: due diligence, the assessment domains, scoring and decision, conditions and risk acceptance, requalification triggers, and records, with a filled specimen and the regulations it satisfies.

Document type: SOP

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use SOP for qualifying and selecting clinical CROs and service providers before award. Oversight starts before a contract is signed; you cannot oversee your way out of choosing the wrong provider. Replace every <<FILL: ...>> placeholder with your own specifics, set your document numbers and dates, and route it through your normal document control, review, and approval. A worked filled specimen follows. Confirm each cited regulation against the current source before you rely on it. This content is general educational reference, not legal or regulatory advice.

Document control header

FieldEntry
Document titleCRO and Service Provider Qualification and Selection
Document number<<FILL: e.g. SOP-CQA-021>>
Version<<FILL: e.g. 1.0>>
Effective date<<FILL: date>>
Supersedes<<FILL: prior version or "New">>
Document owner<<FILL: role, e.g. Head of Clinical QA>>
Applies to<<FILL: clinical programs / functions in scope>>

1. Purpose

Define how <<FILL: COMPANY NAME>> qualifies clinical CROs and service providers (a documented decision that a provider is capable of doing the work to GxP standards) and selects among qualified providers for a specific scope, so that delegated trial duties go to competent parties and the decision is defensible in an inspection.

2. Scope

Applies to any third party proposed to carry a trial-related activity: full-service CROs, functional-service providers, central labs, EDC/IRT/eTMF vendors, PV vendors, imaging, couriers, and their subcontractors where the sponsor requires direct qualification. Depth scales with risk (section 5). It does not replace ongoing oversight, which is governed by the sponsor oversight plan and <<FILL: oversight SOP ref>>.

3. Responsibilities

RoleResponsibility
Clinical QAOwns the qualification program; performs or commissions assessments and audits; approves the qualification decision.
Clinical operations / program leadDefines the scope and requirements; participates in selection; owns the relationship after award.
Data management / DIAssesses data-holding providers (validation, access, audit trail, data residency).
Procurement / contractsRuns the commercial process; ensures the contract reflects the qualification conditions.
ProviderSupplies the requested evidence honestly and completely.

4. Definitions

  • Qualification: the documented determination that a provider is capable of performing defined GxP activities to standard, before award.
  • Selection: choosing among qualified providers for a specific study or scope.
  • Requalification: periodic or triggered re-confirmation that a provider remains qualified.
  • Service provider: any third party performing trial-related activities, per ICH E6(R3).

5. Procedure

5.1 Determine the risk tier

Set the assessment depth from what the provider will do and how much it could hurt the trial.

Risk tierTypical scopeMinimum qualification depth
HighPV/safety reporting, EDC holding the primary endpoint, full-service conduct, GxP data hostingOn-site or detailed remote audit before award, plus full assessment
MediumCentral lab, IRT, eTMF, specialty monitoringDetailed questionnaire + evidence review; audit risk-based
LowTranslation, kit supply, non-GxP servicesQuestionnaire + references

5.2 Run the assessment (domains)

Assess, proportionate to tier:

  1. Quality system: current, controlled, followed SOPs; CAPA; deviation and change control; internal audit; management review. Request the SOP index and redacted recent CAPAs.
  2. Regulatory and inspection history: prior FDA/EMA/MHRA inspections, Form 483s, warning letters, and how they were closed.
  3. Experience and capacity: therapeutic area, phase, and modality experience; headcount; the risk of overcommitment to junior staff.
  4. Personnel and training: qualifications and GCP training currency of the people who will actually work on the study.
  5. Computer systems and data integrity: system validation, role-based access, audit trails on and reviewed, backup and restore, data hosting and residency.
  6. Financial stability and business continuity: financial health; disaster recovery and continuity plans, so a provider failure mid-trial does not strand data.
  7. Subcontractor governance: whether and to whom they subcontract, and how they qualify and oversee those subcontractors.

5.3 Score and decide

  1. Score each domain against defined criteria (section 6) and record evidence, not assertion.
  2. Reach a decision: Qualified, Qualified with conditions, or Not qualified.
  3. Record any conditions, risks accepted, and their owner and due date.
  4. Clinical QA approves the decision.

5.4 Select for a study

Among qualified providers, select for the specific scope on defined criteria (capability fit, capacity, therapeutic experience, cost, timelines, conflicts). Record the selection rationale.

5.5 Requalify

Requalify on a defined cycle (commonly every two to three years for active high-risk providers) and on any material trigger: a merger, a platform move, a cluster of quality issues, a failed audit, or a significant scope change.

6. Acceptance criteria

  • The provider was assessed at the depth its risk tier requires before award.
  • Each domain has an evidence-backed score, not an assertion.
  • The decision, conditions, accepted risks, and owner are documented and QA-approved.
  • Higher-risk providers were audited before award where the tier requires it.
  • Requalification cycle and triggers are defined and tracked.

7. Records generated

  • Qualification assessment report (scored, with evidence references).
  • Audit report and CAPAs where an audit was performed.
  • Qualification decision record with conditions and risk acceptances.
  • Selection rationale.
  • Requalification schedule and records.

8. References

ICH E6(R3) Good Clinical Practice, sponsor use and oversight of service providers. 21 CFR 312.50 and 312.52 (sponsor responsibilities; transfer of obligations). ICH E8(R1), General Considerations for Clinical Studies (quality by design in provider selection).

Confirm the in-force version for every region the study touches before issue.

9. Revision history

VersionDateAuthorSummary of change
<<FILL: 1.0>><<FILL: date>><<FILL: author>>Initial issue.

10. Approvals

RoleNameSignatureDate
Author<<FILL>>
Reviewer (QA)<<FILL>>
Approver<<FILL>>

Filled specimen

Illustrative qualification decision for a PV/safety-reporting vendor (High risk).

Provider: illustrative PV vendor. Scope: SAE case processing and expedited reporting support for a Phase 2 program. Risk tier: High (safety reporting). Assessment: on-site audit AUD-2026-014 plus full domain review.

DomainScore (1 to 5)EvidenceNote
Quality system4SOP index current; 3 CAPAs closed on timeAdequate
Regulatory / inspection history4One FDA inspection, no 483; documentedReassuring
Experience and capacity3Right therapeutic area; capacity tightCondition: confirm named staff
Personnel and training4GCP training current for named teamAdequate
Computer systems / DI4Validated safety DB, access reviewed, audit trail onAdequate
Financial / continuity3Stable; continuity plan reviewedAdequate
Subcontractor governance5No subcontracting for this scopeSimplest case

Decision: Qualified with conditions. Conditions: (1) confirm the named case-processing team before the first work order; (2) re-audit in 24 months or on any safety-reporting timeliness breach. QA approved. Selection followed for study XYZ-201 with the rationale recorded separately.

The value of the record is the condition, not the score: capacity was the real risk, so the qualification pins the named team and sets an early re-look trigger.

Common inspection findings this SOP prevents

  • A provider used with no documented qualification, so the sponsor cannot show it chose a competent party.
  • A high-risk provider (PV, EDC holding the endpoint) awarded with only a questionnaire, no audit.
  • A qualification that lives in someone’s head, with no scored, evidence-backed record.
  • No requalification, so a provider that degraded or changed platforms is still treated as qualified.
  • Subcontracting never assessed, so a critical activity sits with an unqualified party two layers down.

How to adapt this SOP

  1. Set the risk-tier table to your own thresholds and the provider types you actually use.
  2. Define the scoring criteria for each domain so scores are repeatable across assessors.
  3. Require an audit before award for the tiers where risk justifies it, and record when it was waived and why.
  4. Track requalification dates and triggers; a merger or platform move should force a re-look. Pair this SOP with the transfer-of-obligations matrix and the sponsor oversight plan.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.